First Epivida Clinical Restoration Target
EPH-101
Epivida is developing a new class of programmable regenerative medicines built from Peptide Nucleic Acid (PNA) targeting molecules and engineered DNA/RNA scaffolds. Our modular platform is designed to precisely activate endogenous genes involved in tissue repair, enabling deep tissue penetration and systemic delivery through a compact, non-viral architecture.
Our lead programs focus on restoring muscle function in age-related mobility disability by reactivating the body’s own regenerative pathways, promoting muscle regeneration, mitochondrial biogenesis, and recovery of strength and physical performance.
PNAfuse™ Epigenetic Reprogramming Technology
Our precision epigenetic rewriting platform. It uses modular peptide nucleic acid anchors to home in on precise coordinates within a target gene, recruiting natural modifiers to rewrite the epigenome without ever cutting DNA.
